What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion.
| Author | |
|---|---|
| Abstract |
:
Lisdexamfetamine dimesylate (LDX) is a prodrug approved for attention deficit/hyperactivity disorder and for moderate-to-severe binge eating disorder in adults in some countries. |
| Year of Publication |
:
2022
|
| Journal |
:
Expert review of clinical pharmacology
|
| Volume |
:
15
|
| Issue |
:
8
|
| Number of Pages |
:
921-925
|
| ISSN Number |
:
1751-2433
|
| URL |
:
https://www.tandfonline.com/doi/full/10.1080/17512433.2022.2112950
|
| DOI |
:
10.1080/17512433.2022.2112950
|
| Short Title |
:
Expert Rev Clin Pharmacol
|
| Download citation |
